Futura Medical plc
FAMDF
$0.01
-$0.01-29.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -84.86% | -85.80% | 410.90% | 409.34% | 314.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -84.86% | -85.80% | 410.90% | 409.34% | 314.19% |
| Cost of Revenue | -63.18% | -65.46% | 298.37% | 297.09% | 176.57% |
| Gross Profit | -94.66% | -94.99% | 480.22% | 478.38% | 434.38% |
| SG&A Expenses | 93.75% | 81.73% | -23.64% | -23.87% | 66.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.35% | 24.14% | 4.69% | 4.37% | 70.09% |
| Operating Income | -968.70% | -914.78% | 108.74% | 108.71% | 142.17% |
| Income Before Tax | -917.00% | -866.22% | 108.86% | 108.84% | 144.58% |
| Income Tax Expenses | 21.60% | 26.40% | 176.53% | 176.19% | 31.95% |
| Earnings from Continuing Operations | -796.25% | -753.03% | 106.32% | 106.30% | 157.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -796.25% | -753.03% | 106.32% | 106.30% | 157.39% |
| EBIT | -968.70% | -914.78% | 108.74% | 108.71% | 142.17% |
| EBITDA | -902.49% | -852.67% | 110.16% | 110.12% | 146.78% |
| EPS Basic | -790.48% | -752.38% | 106.12% | 106.00% | 155.26% |
| Normalized Basic EPS | -936.36% | -890.91% | 109.38% | 109.23% | 140.74% |
| EPS Diluted | -825.00% | -785.00% | 105.10% | 106.00% | 152.63% |
| Normalized Diluted EPS | -936.36% | -890.91% | 109.38% | 109.23% | 140.74% |
| Average Basic Shares Outstanding | 0.77% | 0.77% | 0.63% | 0.63% | 4.34% |
| Average Diluted Shares Outstanding | -4.29% | -4.29% | 1.08% | 1.08% | 9.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |